BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29194293)

  • 1. Multiple pathological mechanisms contribute to hippocampal damage in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Kyran EL; Robinson C; Kocovski P; Li Z; Dang PT; Hale MW; Orian JM
    Neuroreport; 2018 Jan; 29(1):19-24. PubMed ID: 29194293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior.
    Kocovski P; Tabassum-Sheikh N; Marinis S; Dang PT; Hale MW; Orian JM
    Front Immunol; 2021; 12():639650. PubMed ID: 34177891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis.
    Khorooshi R; Mørch MT; Holm TH; Berg CT; Dieu RT; Dræby D; Issazadeh-Navikas S; Weiss S; Lienenklaus S; Owens T
    Acta Neuropathol; 2015 Jul; 130(1):107-18. PubMed ID: 25869642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis.
    Bonfiglio T; Olivero G; Merega E; Di Prisco S; Padolecchia C; Grilli M; Milanese M; Di Cesare Mannelli L; Ghelardini C; Bonanno G; Marchi M; Pittaluga A
    PLoS One; 2017; 12(1):e0170825. PubMed ID: 28125677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.
    Ziehn MO; Avedisian AA; Tiwari-Woodruff S; Voskuhl RR
    Lab Invest; 2010 May; 90(5):774-86. PubMed ID: 20157291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegeneration and inflammation in hippocampus in experimental autoimmune encephalomyelitis induced in rats by one--time administration of encephalitogenic T cells.
    Kurkowska-Jastrzębska I; Swiątkiewicz M; Zaremba M; Cudna A; Piechal A; Pyrzanowska J; Widy-Tyszkiewicz E; Członkowska A
    Neuroscience; 2013 Sep; 248():690-8. PubMed ID: 23806721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitis.
    de Bruin NM; Schmitz K; Schiffmann S; Tafferner N; Schmidt M; Jordan H; Häußler A; Tegeder I; Geisslinger G; Parnham MJ
    Behav Brain Res; 2016 Mar; 300():160-74. PubMed ID: 26692368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aluminum excytotoxicity and neuroautotoimmunity: the role of the brain expression of CD32+ (FcγRIIa), ICAM-1+ and CD3ξ in aging.
    Jovanova-Nesic K; Shoenfeld Y; Spector NH
    Curr Aging Sci; 2012 Dec; 5(3):209-17. PubMed ID: 23387884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxemia-induced cytokine-mediated responses of hippocampal astrocytes transmitted by cells of the brain-immune interface.
    Hasegawa-Ishii S; Inaba M; Umegaki H; Unno K; Wakabayashi K; Shimada A
    Sci Rep; 2016 May; 6():25457. PubMed ID: 27149601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis.
    Bail K; Notz Q; Rovituso DM; Schampel A; Wunsch M; Koeniger T; Schropp V; Bharti R; Scholz CJ; Foerstner KU; Kleinschnitz C; Kuerten S
    J Neuroinflammation; 2017 Jul; 14(1):148. PubMed ID: 28738885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butylphthalide ameliorates experimental autoimmune encephalomyelitis by suppressing PGAM5-induced necroptosis and inflammation in microglia.
    Wang Y; Bi Y; Xia Z; Shi W; Li B; Li B; Chen L; Guo L
    Biochem Biophys Res Commun; 2018 Feb; 497(1):80-86. PubMed ID: 29407174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice.
    Peferoen LA; Breur M; van de Berg S; Peferoen-Baert R; Boddeke EH; van der Valk P; Pryce G; van Noort JM; Baker D; Amor S
    Immunology; 2016 Oct; 149(2):146-56. PubMed ID: 27388634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR7 suppression modulates microglial chemotaxis to ameliorate experimentally-induced autoimmune encephalomyelitis.
    Bao J; Zhu J; Luo S; Cheng Y; Zhou S
    Biochem Biophys Res Commun; 2016 Jan; 469(1):1-7. PubMed ID: 26607112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis.
    Jones MV; Nguyen TT; Deboy CA; Griffin JW; Whartenby KA; Kerr DA; Calabresi PA
    J Neuroimmunol; 2008 Aug; 199(1-2):83-93. PubMed ID: 18582952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis.
    Bourel J; Planche V; Dubourdieu N; Oliveira A; Séré A; Ducourneau EG; Tible M; Maitre M; Lesté-Lasserre T; Nadjar A; Desmedt A; Ciofi P; Oliet SH; Panatier A; Tourdias T
    Neurobiol Dis; 2021 Dec; 160():105533. PubMed ID: 34673149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation.
    Ding Z; Mathur V; Ho PP; James ML; Lucin KM; Hoehne A; Alabsi H; Gambhir SS; Steinman L; Luo J; Wyss-Coray T
    J Exp Med; 2014 Feb; 211(2):189-98. PubMed ID: 24493798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein.
    Columba-Cabezas S; Griguoli M; Rosicarelli B; Magliozzi R; Ria F; Serafini B; Aloisi F
    J Neuroimmunol; 2006 Oct; 179(1-2):76-86. PubMed ID: 16870269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.
    Clark KC; Josephson A; Benusa SD; Hartley RK; Baer M; Thummala S; Joslyn M; Sword BA; Elford H; Oh U; Dilsizoglu-Senol A; Lubetzki C; Davenne M; DeVries GH; Dupree JL
    Glia; 2016 Jul; 64(7):1190-209. PubMed ID: 27100937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent activation of microglia and NADPH oxidase [corrected] drive hippocampal dysfunction in experimental multiple sclerosis.
    Di Filippo M; de Iure A; Giampà C; Chiasserini D; Tozzi A; Orvietani PL; Ghiglieri V; Tantucci M; Durante V; Quiroga-Varela A; Mancini A; Costa C; Sarchielli P; Fusco FR; Calabresi P
    Sci Rep; 2016 Feb; 6():20926. PubMed ID: 26887636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of system x
    Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
    J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.